These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

674 related items for PubMed ID: 16294501

  • 1. Investigation of pharmacokinetic data of hypericin, pseudohypericin, hyperforin and the flavonoids quercetin and isorhamnetin revealed from single and multiple oral dose studies with a hypericum extract containing tablet in healthy male volunteers.
    Schulz HU, Schürer M, Bässler D, Weiser D.
    Arzneimittelforschung; 2005; 55(10):561-8. PubMed ID: 16294501
    [Abstract] [Full Text] [Related]

  • 2. Investigation of the bioavailability of hypericin, pseudohypericin, hyperforin and the flavonoids quercetin and isorhamnetin following single and multiple oral dosing of a hypericum extract containing tablet.
    Schulz HU, Schürer M, Bässler D, Weiser D.
    Arzneimittelforschung; 2005; 55(1):15-22. PubMed ID: 15727160
    [Abstract] [Full Text] [Related]

  • 3. Oral bioavailability of hyperforin from hypericum extracts in rats and human volunteers.
    Biber A, Fischer H, Römer A, Chatterjee SS.
    Pharmacopsychiatry; 1998 Jun; 31 Suppl 1():36-43. PubMed ID: 9684946
    [Abstract] [Full Text] [Related]

  • 4. Oral bioavailability of active principles from herbal products in humans. A study on Hypericum perforatum extracts using the soft gelatin capsule technology.
    Agrosi M, Mischiatti S, Harrasser PC, Savio D.
    Phytomedicine; 2000 Dec; 7(6):455-62. PubMed ID: 11194173
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics of hypericin and pseudohypericin after oral intake of the hypericum perforatum extract LI 160 in healthy volunteers.
    Staffeldt B, Kerb R, Brockmöller J, Ploch M, Roots I.
    J Geriatr Psychiatry Neurol; 1994 Oct; 7 Suppl 1():S47-53. PubMed ID: 7857509
    [Abstract] [Full Text] [Related]

  • 6. Hypericum perforatum: a 'modern' herbal antidepressant: pharmacokinetics of active ingredients.
    Wurglics M, Schubert-Zsilavecz M.
    Clin Pharmacokinet; 2006 Oct; 45(5):449-68. PubMed ID: 16640452
    [Abstract] [Full Text] [Related]

  • 7. Step by step removal of hyperforin and hypericin: activity profile of different Hypericum preparations in behavioral models.
    Butterweck V, Christoffel V, Nahrstedt A, Petereit F, Spengler B, Winterhoff H.
    Life Sci; 2003 Jun 20; 73(5):627-39. PubMed ID: 12770617
    [Abstract] [Full Text] [Related]

  • 8. Simultaneous determination of the predominant hyperforins and hypericins in St. John's Wort (Hypericum perforatum L.) by liquid chromatography.
    Gray DE, Rottinghaus GE, Garrett HE, Pallardy SG, Gray DE, Rottinghaus GE, Garrett HE, Pallardy SG.
    J AOAC Int; 2000 Jun 20; 83(4):944-9. PubMed ID: 10995119
    [Abstract] [Full Text] [Related]

  • 9. Simultaneous determination of total hypericin and hyperforin in St. John's wort extracts by HPLC with electrochemical detection.
    Rückert U, Likussar W, Michelitsch A.
    Phytochem Anal; 2007 Jun 20; 18(3):204-8. PubMed ID: 17500362
    [Abstract] [Full Text] [Related]

  • 10. Effects of a methanolic extract and a hyperforin-enriched CO2 extract of St. John's Wort (Hypericum perforatum) on intracerebral field potentials in the freely moving rat (Tele-Stereo-EEG).
    Dimpfel W, Schober F, Mannel M.
    Pharmacopsychiatry; 1998 Jun 20; 31 Suppl 1():30-5. PubMed ID: 9684945
    [Abstract] [Full Text] [Related]

  • 11. Understanding drug interactions with St John's wort (Hypericum perforatum L.): impact of hyperforin content.
    Chrubasik-Hausmann S, Vlachojannis J, McLachlan AJ.
    J Pharm Pharmacol; 2019 Jan 20; 71(1):129-138. PubMed ID: 29411879
    [Abstract] [Full Text] [Related]

  • 12. Researching the antidepressant actions of Hypericum perforatum (St. John's wort) in animals and man.
    Franklin M, Cowen PJ.
    Pharmacopsychiatry; 2001 Jul 20; 34 Suppl 1():S29-37. PubMed ID: 11518072
    [Abstract] [Full Text] [Related]

  • 13. St. John's wort components and the brain: uptake, concentrations reached and the mechanisms underlying pharmacological effects.
    Caccia S, Gobbi M.
    Curr Drug Metab; 2009 Nov 20; 10(9):1055-65. PubMed ID: 20214594
    [Abstract] [Full Text] [Related]

  • 14. St. John's wort flavonoids and their metabolites show antidepressant activity and accumulate in brain after multiple oral doses.
    Paulke A, Nöldner M, Schubert-Zsilavecz M, Wurglics M.
    Pharmazie; 2008 Apr 20; 63(4):296-302. PubMed ID: 18468390
    [Abstract] [Full Text] [Related]

  • 15. Determination of hyperforin, hypericin, and pseudohypericin in human plasma using high-performance liquid chromatography analysis with fluorescence and ultraviolet detection.
    Bauer S, Störmer E, Graubaum HJ, Roots I.
    J Chromatogr B Biomed Sci Appl; 2001 Dec 05; 765(1):29-35. PubMed ID: 11817306
    [Abstract] [Full Text] [Related]

  • 16. [Hypericin and hyperforin: bioactive components of St. John's Wort (Hypericum perforatum). Their isolation, analysis and study of physiological effect].
    Vacek J, Klejdus B, Kubán V.
    Ceska Slov Farm; 2007 Apr 05; 56(2):62-6. PubMed ID: 17619301
    [Abstract] [Full Text] [Related]

  • 17. Pharmacodynamic effects of two different hypericum extracts in healthy volunteers measured by quantitative EEG.
    Schellenberg R, Sauer S, Dimpfel W.
    Pharmacopsychiatry; 1998 Jun 05; 31 Suppl 1():44-53. PubMed ID: 9684947
    [Abstract] [Full Text] [Related]

  • 18. The extent of induction of CYP3A by St. John's wort varies among products and is linked to hyperforin dose.
    Mueller SC, Majcher-Peszynska J, Uehleke B, Klammt S, Mundkowski RG, Miekisch W, Sievers H, Bauer S, Frank B, Kundt G, Drewelow B.
    Eur J Clin Pharmacol; 2006 Jan 05; 62(1):29-36. PubMed ID: 16341856
    [Abstract] [Full Text] [Related]

  • 19. Hypericin levels in human serum and interstitial skin blister fluid after oral single-dose and steady-state administration of Hypericum perforatum extract (St. John's wort).
    Schempp CM, Winghofer B, Langheinrich M, Schöpf E, Simon JC.
    Skin Pharmacol Appl Skin Physiol; 1999 Jan 05; 12(5):299-304. PubMed ID: 10461100
    [Abstract] [Full Text] [Related]

  • 20. Development of a simple, rapid and reproducible HPLC assay for the simultaneous determination of hypericins and stabilized hyperforin in commercial St. John's wort preparations.
    de los Reyes GC, Koda RT.
    J Pharm Biomed Anal; 2001 Dec 05; 26(5-6):959-65. PubMed ID: 11600308
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.